Literature DB >> 11776065

Risk factors for development of diabetes mellitus in women with a history of gestational diabetes mellitus.

X Bian1, P Gao, X Xiong, H Xu, M Qian, S Liu.   

Abstract

OBJECTIVE: To determine whether diabetes recurs in their later life when women have a history of gestational diabetes mellitus (GDM) or abnormal glucose tolerance test (impaired glucose tolerance, IGT).
METHODS: Three groups of women were investigated at 5-10 years postpartum. GDM group (n = 45) had been diagnosed as having GDM in their previous pregnancy. IGT group (n = 31) had a history of abnormal glucose tolerance test during previous pregnancy. Normal control group (n = 39) was normal previous pregnant population. Their previous obstetric and medical histories were thoroughly reviewed. Fasting plasma glucose (FPG) and oral glucose (75 g) tolerance test (OGTT) were repeated in all women.
RESULTS: Diabetes mellitus (DM) was diagnosed in 33.3% of patients in the GDM group, while in 9.7% in the IGT group and in 2.6% in the normal control group. Incidence of recurring DM in later life was significant higher in the GDM group (P = 0.017). When one or more blood glucose values exceeding WHO criteria for diagnosis of diabetes in their previous pregnancy, the incidence of DM in later life was 60% (3/5, including GDM in women having four abnormal OGTT values), 41.7% (5/12) in women having three, 25% (7/28) in women having two and 9.7% (3/31) in women having one. The women with DM, also with a history of GDM and abnormal OGTT in previous pregnancy, tends to have a high pregnant body mass index (BMI > 25 kg/m2).
CONCLUSION: The women suffering from GDM during previous pregnancy have a high risk of recurrence DM. Two or more abnormal OGTT values during pregnancy, blood glucose level exceeding the maximal values at 1 and 2 hours after oral glucose loading and high pregnant BMI are concluded to be useful factors in predicting the recurring DM in their later life.

Entities:  

Mesh:

Year:  2000        PMID: 11776065

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  7 in total

1.  Insulin secretion and tolerance of women with different gestational glucose regulation one year postpartum.

Authors:  Jinhua Wei; Xiaona Li; Jianbo Gao
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 2.  Attenuating type 2 diabetes with postpartum interventions following gestational diabetes mellitus.

Authors:  Sudharshani Wasalathanthri
Journal:  World J Diabetes       Date:  2015-05-15

Review 3.  Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective.

Authors:  Yeyi Zhu; Cuilin Zhang
Journal:  Curr Diab Rep       Date:  2016-01       Impact factor: 4.810

4.  Maternal serum adiponectin multimers in gestational diabetes.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Edi Vaisbuch; Offer Erez; Pooja Mittal; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Percy Pacora; Lami Yeo; Francesca Gotsch; Zhong Dong; Bo Hyun Yoon; Sonia S Hassan; Juan Pedro Kusanovic
Journal:  J Perinat Med       Date:  2009       Impact factor: 1.901

Review 5.  Cardiovascular risk factors in women with previous gestational diabetes mellitus: A systematic review and meta-analysis.

Authors:  Maleesa M Pathirana; Zohra Lassi; Anna Ali; Margaret Arstall; Claire T Roberts; Prabha H Andraweera
Journal:  Rev Endocr Metab Disord       Date:  2020-10-27       Impact factor: 6.514

6.  The effect of a glucagon-like peptide-1 receptor agonist on glucose tolerance in women with previous gestational diabetes mellitus: protocol for an investigator-initiated, randomised, placebo-controlled, double-blinded, parallel intervention trial.

Authors:  Signe Foghsgaard; Louise Vedtofte; Elisabeth R Mathiesen; Jens A Svare; Lise L Gluud; Jens J Holst; Peter Damm; Filip K Knop; Tina Vilsbøll
Journal:  BMJ Open       Date:  2013-10-30       Impact factor: 2.692

Review 7.  Risk of type 2 diabetes mellitus after gestational diabetes mellitus: A systematic review & meta-analysis.

Authors:  Huaxuan You; Juan Hu; Ying Liu; Biru Luo; Anjiang Lei
Journal:  Indian J Med Res       Date:  2021-07       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.